Table 7.
Descriptive statistic for the examined variables in active phase (act) versus remission (rem) subsets of patients with UC or CD depicted in Figure 5.
| Variable | Group | Mean | Standard deviation |
|---|---|---|---|
| Ratio TRP/KYN | Control | 20.97565 | 24.99752 |
| Ratio KYN/KYNA | Control | 0.07759 | 0.03575 |
| Ratio KYN/3-OH-KYN | Control | 1.23464 | 1.15304 |
| Ratio KYNA/3-OH-KYN | Control | 16.48301 | 14.37523 |
| Ratio TRP/KYN | UC act | 12.40523 | 9.55234 |
| Ratio KYN/KYNA | UC act | 0.12830 | 0.14983 |
| Ratio KYN/3-OH-KYN | UC act | 2.14093 | 2.35894 |
| Ratio KYNA/3-OH-KYN | UC act | 17.58799 | 13.93756 |
| Ratio TRP/KYN | UC rem | 12.41870 | 8.565722 |
| Ratio KYN/KYNA | UC rem | 0.20740 | 0.170197 |
| Ratio KYN/3-OH-KYN | UC rem | 1.70524 | 1.307593 |
| Ratio KYNA/3-OH-KYN | UC rem | 10.43040 | 7.410389 |
| Ratio TRP/KYN | CR act | 10.68468 | 7.98902 |
| Ratio KYN/KYNA | CR act | 0.12853 | 0.12342 |
| Ratio KYN/3-OH-KYN | CR act | 3.43799 | 3.18422 |
| Ratio KYNA/3-OH-KYN | CR act | 26.48682 | 17.64786 |
| Ratio TRP/KYN | CR rem | 7.651920 | 8.480039 |
| Ratio LKYN/KYNA | CR rem | 0.258654 | 0.203501 |
| Ratio KYN/3-OH-KYN | CR rem | 2.240854 | 1.945990 |
| Ratio KYNA/3-OH-KYN | CR rem | 6.505416 | 2.911304 |
3-OH-KYN, 3-hydroxykynurenine; CD, Crohn’s disease; KYN, kynurenine; KYNA, kynurenic acid; TRP, tryptophan; UC, ulcerative colitis.